Skip to main content

Clinical Radiation Oncology

Section edited by Stephanie Combs, Pirus Ghadjar, Matthias Guckenberger, Daniel Habermehl, Silke Nachbichler, Maximilian Niyazi, and Falk Roeder

The Clinical Radiation Oncology section aims to provide a platform for clinical research in radiation oncology. Research includes innovative early phase and later stage clinical trials, technical approaches, review articles on “burning” clinical questions, invited key reviews, RT planning studies, multimodal therapy, data mining from retrospective cohorts in a hypothesis-generating manner, interconnection between imaging and improved target delineation, and intensity modulation/high precision techniques. The section addresses current, timely and cutting- edge research and reviews about clinically relevant issues in radiation oncology, while offering a fast review process.

Page 12 of 27

  1. To evaluate the effect of timing of radiotherapy (RT) on survival in patients with newly diagnosed primary glioblastoma (GBM) treated with the same therapeutical protocol.

    Authors: Sotirios Katsigiannis, Boris Krischek, Stefanie Barleanu, Stefan Grau, Norbert Galldiks, Marco Timmer, Christoph Kabbasch, Roland Goldbrunner and Pantelis Stavrinou
    Citation: Radiation Oncology 2019 14:73
    Content type: Research Published on:

  2. An objective way to qualify the effect of radiotherapy (RT) on lung tissue is the analysis of CT scans after RT. In this analysis we focused on the changes in Hounsfield units (ΔHU) and the correlation with th...

    Authors: Christina Schröder, Rita Engenhart-Cabillic, Sven Kirschner, Eyck Blank and André Buchali
    Citation: Radiation Oncology 2019 14:72
    Content type: Research Published on:

  3. Different studies have proved in recent years that hypofractionated radiotherapy (RT) improves overall survival of patients affected by locally advanced, unresectable, pancreatic cancer.

    Authors: Luca Boldrini, Davide Cusumano, Francesco Cellini, Luigi Azario, Gian Carlo Mattiucci and Vincenzo Valentini
    Citation: Radiation Oncology 2019 14:71
    Content type: Review Published on:

  4. Intraductal carcinoma of the prostate (IDC-P) is an independent biomarker of recurrence and survival with particular treatment response, yet no study has tested its response to radiotherapy. The aim of our pro...

    Authors: Vincent Q. Trinh, Nazim Benzerdjeb, Ségolène Chagnon-Monarque, Nicolas Dionne, Guila Delouya, André Kougioumoutzakis, Jennifer Sirois, Roula Albadine, Mathieu Latour, Anne-Marie Mes-Masson, Hélène Hovington, Alain Bergeron, Kevin C. Zorn, Yves Fradet, Fred Saad, Daniel Taussky…
    Citation: Radiation Oncology 2019 14:60
    Content type: Research Published on:

  5. The aim was to evaluate the outcome, especially locoregional control of patients with locally advanced salivary gland carcinoma (SGC) with perineural spread (Pn1) and/or positive resection margins (R1/2) after...

    Authors: Marlen Haderlein, Claudia Scherl, Sabine Semrau, Sebastian Lettmaier, Markus Hecht, Florian Putz, Heinrich Iro, Abbas Agaimy and Rainer Fietkau
    Citation: Radiation Oncology 2019 14:68
    Content type: Research Published on:

  6. Multimodal treatment with neoadjuvant chemoradiation followed by surgery (nCRT + S) is the treatment of choice for patients with locally advanced or node-positive esophageal squamous cell carcinoma (E-SCC). Th...

    Authors: Stefan Münch, Steffi U. Pigorsch, Michal Devečka, Hendrik Dapper, Marcus Feith, Helmut Friess, Wilko Weichert, Moritz Jesinghaus, Rickmer Braren, Stephanie E. Combs and Daniel Habermehl
    Citation: Radiation Oncology 2019 14:66
    Content type: Research Published on:

  7. The differential diagnosis between radiation necrosis, tumor recurrence and tumor progression is crucial for the evaluation of treatment response and treatment planning.

    Authors: Rosa Morabito, Concetta Alafaci, Stefano Pergolizzi, Antonio Pontoriero, Giuseppe Iati’, Lilla Bonanno, Michele Gaeta, Francesco Maria Salpietro, Enricomaria Mormina, Marcello Longo and Francesca Granata
    Citation: Radiation Oncology 2019 14:65
    Content type: Research Published on:

  8. Patients with plasma-cell neoplasia usually suffer from systemic disease, although a minority (< 5%) may present with solitary involvement of bone or soft tissue (extramedullary plasmacytoma (EMP)). Radiothera...

    Authors: Michael Oertel, Khaled Elsayad, Kai Jannes Kroeger, Uwe Haverkamp, Claudia Rudack, Georg Lenz and Hans Theodor Eich
    Citation: Radiation Oncology 2019 14:63
    Content type: Research Published on:

  9. This study investigated the impact of post-radiation sinusitis on the prognosis of nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT).

    Authors: Chih-Jen Huang, Ming-Yii Huang, Ming-Chen Paul Shih, Kai-yuan Cheng, Ka-Wo Lee, Tzu-Ying Lu, Shyng-Shiou Yuan and Pen-Tzu Fang
    Citation: Radiation Oncology 2019 14:61
    Content type: Research Published on:

  10. Although there have been many attempts to increase the therapeutic ratio of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma (MALToma), only a few planning studies have reported the efficacy...

    Authors: Seo Hee Choi, So Hyun Park, Jason Joon Bock Lee, Jong Geol Baek, Jin Sung Kim and Hong In Yoon
    Citation: Radiation Oncology 2019 14:59
    Content type: Research Published on:

  11. Advanced pelvic radiotherapy techniques aim to reduce late bowel toxicity which can severely impact the lives of pelvic cancer survivors. Although advanced techniques have been largely adopted worldwide, to ac...

    Authors: Rashmi Jadon, Emma Higgins, Louise Hanna, Mererid Evans, Bernadette Coles and John Staffurth
    Citation: Radiation Oncology 2019 14:57
    Content type: Review Published on:

  12. It remains unknown which is the most preferable regimen used concurrently with thoracic radiation for locally advanced non-small cell lung cancer (NSCLC). We performed a network meta-analysis to address this i...

    Authors: Tingting Liu, Zheng He, Jun Dang and Guang Li
    Citation: Radiation Oncology 2019 14:55
    Content type: Research Published on:

  13. To validate and propose revision of the 8th edition American Joint Committee on Cancer (AJCC) clinical staging system for esophageal squamous cell cancer (ESCC) patients treated with definitive intensity-modul...

    Authors: Mingqiu Chen, Xiqing Li, Yuangui Chen, Pingping Liu, Zhiwei Chen, Minmin Shen, Xiaohong Liu, Yu Lin, Rongqiang Yang, Wei Ni, Xin Zhou, Lurong Zhang, Ye Tian, Junqiang Chen and Lengxi Fu
    Citation: Radiation Oncology 2019 14:54
    Content type: Research Published on:

  14. To clarify the short- and long-term outcomes of radical surgery after neoadjuvant chemoradiotherapy (NCRT) with TS-1 and irinotecan, which enhances radiosensitivity, in patients with locally advanced rectal ca...

    Authors: Takatoshi Nakamura, Takeo Sato, Kazushige Hayakawa, Wasaburou Koizumi, Yuji Kumagai and Masahiko Watanabe
    Citation: Radiation Oncology 2019 14:53
    Content type: Research Published on:

  15. Few patients with pancreatic cancer may be candidates for immediate surgical resection at the initial diagnosis. Even if patients with borderline resectable pancreatic cancer (BRPC), micrometastases may occur ...

    Authors: Suizhi Gao, Xiaofei Zhu, Xiaohan Shi, Kai Cao, Yun Bian, Hui Jiang, Kaixuan Wang, Shiwei Guo, Huojun Zhang and Gang Jin
    Citation: Radiation Oncology 2019 14:52
    Content type: Study protocol Published on:

  16. Immunotherapy is currently being examined as a treatment modality for glioblastoma. Maintaining an optimal total lymphocyte count (TLC) after radiotherapy (RT) and using temozolomide may be beneficial in optim...

    Authors: Hwa Kyung Byun, Nalee Kim, Hong In Yoon, Seok-Gu Kang, Se Hoon Kim, Jaeho Cho, Jong Geol Baek, Jong Hee Chang and Chang-Ok Suh
    Citation: Radiation Oncology 2019 14:51
    Content type: Research Published on:

  17. Child-Turcotte-Pugh (CTP) score extensively used to assess hepatic function, predicting postoperative outcome of hepatocellular carcinoma (HCC) patients. Lately, the albumin–bilirubin (ALBI) grade has been ide...

    Authors: Ting-Shi Su, Hai-Ming Yang, Ying Zhou, Yong Huang, Ping Liang, Tao Cheng, Long Chen, Le-Qun Li and Shi-Xiong Liang
    Citation: Radiation Oncology 2019 14:50
    Content type: Research Published on:

  18. Literature has shown a significant relationship between radiation dose to the larynx and swallowing disorders. We prospectively studied the dose-volume relationship for larynx substructures and aspiration.

    Authors: Katarina G. Petras, Alfred W. Rademaker, Tamer Refaat, Mehee Choi, Tarita O. Thomas, Barbara R. Pauloski and Bharat B. Mittal
    Citation: Radiation Oncology 2019 14:49
    Content type: Research Published on:

  19. To investigate the safety and tolerability of simultaneous integrated boost (SIB) technique concurrent with elective nodal irradiation (ENI) and dual-drug chemotherapy for patients with unresectable esophageal...

    Authors: Chen Li, Wenjie Ni, Xin Wang, Zongmei Zhou, Wei Deng, Xiao Chang, Dongfu Chen, Qinfu Feng, Jun Liang, Xiaozhen Wang, Lei Deng, Wenqing Wang, Nan Bi, Tao Zhang and Zefen Xiao
    Citation: Radiation Oncology 2019 14:48
    Content type: Research Published on:

  20. Rectal spacers are used to limit dose to the anterior rectal wall in high dose external beam radiation therapy of the prostate and have been shown to reduce radiation induced toxicity. Here we report the compl...

    Authors: Andreas Schörghofer, Martin Drerup, Thomas Kunit, Lukas Lusuardi, Josef Holzinger, Josef Karner, Michael Groher, Christoph Zoubek, Rosemarie Forstner, Felix Sedlmayer and Frank Wolf
    Citation: Radiation Oncology 2019 14:47
    Content type: Research Published on:

  21. Administering stereotactic radiotherapy to the surgical cavity and thus omitting postoperative whole brain radiotherapy (WBRT) is a favored strategy in limited metastatic brain disease. Little is known about t...

    Authors: N. Bachmann, D. Leiser, E. Ermis, S. Vulcu, P. Schucht, A. Raabe, D. M. Aebersold and E. Herrmann
    Citation: Radiation Oncology 2019 14:45
    Content type: Research Published on:

  22. Despite development of several next-generation tyrosine kinase inhibitors (TKIs), crizotinib remains one of the first-line treatment options for advanced ALK-positive NSCLC and is widely used in situations where ...

    Authors: Jianjiao Ni, Guodong Li, Xi Yang, Li Chu, Jialei Wang, Yida Li, Liqing Zou, Yuan Li, Congying Xie and Zhengfei Zhu
    Citation: Radiation Oncology 2019 14:44
    Content type: Research Published on:

  23. To develop and compare delta-radiomics signatures from 2- (2D) and 3-dimensional (3D) features that predict treatment outcomes following preoperative chemoradiotherapy (CCRT) and surgery for locally advanced r...

    Authors: Seung Hyuck Jeon, Changhoon Song, Eui Kyu Chie, Bohyoung Kim, Young Hoon Kim, Won Chang, Yoon Jin Lee, Joo-Hyun Chung, Jin Beom Chung, Keun-Wook Lee, Sung-Bum Kang and Jae-Sung Kim
    Citation: Radiation Oncology 2019 14:43
    Content type: Research Published on:

  24. Radiotherapy plays a major role in the management of brain metastases. This study aimed to identify the subset of patients with multiple brain metastases who may not benefit from whole brain irradiation (WBI) ...

    Authors: Rebecca Buecker, Zhen-Yu Hong, Xiao-Mei Liu, Gert Jaenke, Ping Lu and Ulrich Schaefer
    Citation: Radiation Oncology 2019 14:41
    Content type: Research Published on:

  25. To assess the relationship between radiation doses to the coronary arteries (CAs) and location of a coronary stenosis that required intervention after three-dimensional conformal radiotherapy (3DCRT) for breas...

    Authors: Anna-Karin Wennstig, Hans Garmo, Ulf Isacsson, Giovanna Gagliardi, Niina Rintelä, Bo Lagerqvist, Lars Holmberg, Carl Blomqvist, Malin Sund and Greger Nilsson
    Citation: Radiation Oncology 2019 14:40
    Content type: Research Published on:

  26. Arm-lymphedema is a major complication after breast cancer. Recent studies demonstrate the validity of predicting Breast Cancer Related Lymphedema (BCRL) by self-reports. We aimed to investigate the rate of BCRL ...

    Authors: Julia Rupp, Catarina Hadamitzky, Christoph Henkenberens, Hans Christiansen, Diana Steinmann and Frank Bruns
    Citation: Radiation Oncology 2019 14:39
    Content type: Research Published on:

  27. To explore the differences and correlations between the target volumes defined using preoperative prone diagnostic magnetic resonance imaging (MRI) and postoperative prone computed tomography (CT) simulation i...

    Authors: Ting Yu, Jian Bin Li, Wei Wang, Min Xu, Ying Jie Zhang, Qian Shao, Xi Jun Liu and Liang Xu
    Citation: Radiation Oncology 2019 14:38
    Content type: Research Published on:

  28. Subventricular zone (SVZ) involvement is associated with a dismal prognosis in patients with glioblastoma multiforme (GBM). Dual-time point (dtp) O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET/CT (PET) may be a time...

    Authors: Maciej Harat, Bogdan Małkowski and Krzysztof Roszkowski
    Citation: Radiation Oncology 2019 14:37
    Content type: Research Published on:

  29. To evaluate the prognostic value of metabolic parameters of pre-treatment and interim 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for overall survival (OS) of esophageal cancer(EC) patients...

    Authors: Yimin Li, Sebastian Zschaeck, Qin Lin, Sijia Chen, Lili Chen and Hua Wu
    Citation: Radiation Oncology 2019 14:35
    Content type: Research Published on:

  30. Salvage surgery of recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) results in limited local control and survival rates. As a result of recent technological progress, radiotherapy (RT) has ...

    Authors: Sati Akbaba, Thomas Held, Kristin Lang, Juliane Hoerner-Rieber, Karim Zaoui, Tobias Forster, Stefan Rieken, Peter Plinkert, Juergen Debus and Sebastian Adeberg
    Citation: Radiation Oncology 2019 14:34
    Content type: Research Published on:

  31. Different management options exist for patients with brain metastases from non-small cell lung cancer (NSCLC), patients whose treatment with whole brain radiotherapy (WBRT) has become more controversial over t...

    Authors: Carsten Nieder, Matthias Guckenberger, Laurie E. Gaspar, Chad G. Rusthoven, Dirk De Ruysscher, Arjun Sahgal, Timothy Nguyen, Anca L. Grosu and Minesh P. Mehta
    Citation: Radiation Oncology 2019 14:33
    Content type: Research Published on:

  32. Concurrent chemoradiotherapy with cisplatin is standard for patients (pts) with loco-regionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) and for patients with resected SCCHN with high-r...

    Authors: Seth Helfenstein, Oliver Riesterer, Urs R. Meier, Alexandros Papachristofilou, Benjamin Kasenda, Miklos Pless and Sacha I. Rothschild
    Citation: Radiation Oncology 2019 14:32
    Content type: Research Published on:

  33. In patients with T4 nasopharyngeal carcinoma (NPC), death may occur prior to the occurrence of temporal lobe injury (TLI). Because such competing risk death precludes the occurrence of TLI and thus the competi...

    Authors: Juan Huang, Fang-fang Kong, Ronald Wihal Oei, Rui-ping Zhai, Chao-su Hu and Hong-mei Ying
    Citation: Radiation Oncology 2019 14:31
    Content type: Research Published on:

  34. Intra-individual heterogeneity of cardiac exposure is an issue in breast cancer (BC) radiotherapy that was poorly considered in previous cardiotoxicity studies mainly based on mean heart dose (MHD). This dosim...

    Authors: Sophie Jacob, Jérémy Camilleri, Sylvie Derreumaux, Valentin Walker, Olivier Lairez, Mathieu Lapeyre, Eric Bruguière, Atul Pathak, Marie-Odile Bernier, Dominique Laurier, Jean Ferrieres, Olivier Gallocher, Igor Latorzeff, Baptiste Pinel, Denis Franck, Christian Chevelle…
    Citation: Radiation Oncology 2019 14:29
    Content type: Research Published on:

  35. This systematic review aims to elucidate the diagnostic accuracy of radiological examinations to distinguish between brain radiation necrosis (BRN) and tumor progression (TP).

    Authors: Motomasa Furuse, Naosuke Nonoguchi, Kei Yamada, Tohru Shiga, Jean-Damien Combes, Naokado Ikeda, Shinji Kawabata, Toshihiko Kuroiwa and Shin-Ichi Miyatake
    Citation: Radiation Oncology 2019 14:28
    Content type: Review Published on:

  37. The SCOPE trials (SCOPE 1, NeoSCOPE and SCOPE 2) have been the backbone of oesophageal RT trials in the UK. Many changes in oesophageal RT techniques have taken place in this time. The SCOPE trials have, in ad...

    Authors: S. Gwynne, E. Higgins, A. Poon King, G. Radhakrishna, L. Wills, S. Mukherjee, Maria Hawkins, G. Jones, J. Staffurth and T. Crosby
    Citation: Radiation Oncology 2019 14:26
    Content type: Research Published on:

  38. Carbon ion radiotherapy (CIRT) has been delivered to more than 20,000 patients worldwide. International trials have been recommended in order to emphasize the actual benefits. The ULICE program (Union of Light...

    Authors: G. Vogin, A. Wambersie, M. Koto, T. Ohno, M. Uhl, P. Fossati and J. Balosso
    Citation: Radiation Oncology 2019 14:24
    Content type: Research Published on:

  39. To compare WBC counts during treatment of localized prostate cancer with either conventionally fractionated (CF) or moderately hypofractionated (HYPO) radiotherapy.

    Authors: Giuseppe Sanguineti, Diana Giannarelli, Maria Grazia Petrongari, Stefano Arcangeli, Angelo Sangiovanni, Biancamaria Saracino, Alessia Farneti, Adriana Faiella, Mario Conte and Giorgio Arcangeli
    Citation: Radiation Oncology 2019 14:23
    Content type: Research Published on:

  40. Three-dimensional ultrasound (3DUS) is an attractive option in image-guided radiotherapy (IGRT) for prostate cancer (PCa) patients. However, the potential factors influencing the accuracy of 3DUS in comparison...

    Authors: Sha Zhou, Liling Luo, Jibin Li, Maosheng Lin, Li Chen, Jianhui Shao, Shipei Lu, Yaru Ma, Yingting Zhang, Wenfen Chen, Mengzhong Liu, Shiliang Liu and Liru He
    Citation: Radiation Oncology 2019 14:22
    Content type: Research Published on:

  41. Despite the advances in oncology, patients with bulky tumors have worse prognosis and often receive only palliative treatments. Bulky disease represents an important challenging obstacle for all currently avai...

    Authors: Slavisa Tubin, Helmut H. Popper and Luka Brcic
    Citation: Radiation Oncology 2019 14:21
    Content type: Methodology Published on:

  42. This study aimed to evaluate the role of postoperative radiotherapy (RT) in dermatofibrosarcoma protuberans (DFSP) and identify the prognostic factors influencing the disease-free survival (DFS).

    Authors: Kaixin Du, Jinluan Li, Lirui Tang, Xiaoyi Lin, Xiangquan Kong, Xuehong Liao, Qingqin Peng, Yaping Dong, Junyan He, Yunxia Huang, Xueqing Zhang, Feifei Lin, Qingyang Zhuang and Junxin Wu
    Citation: Radiation Oncology 2019 14:20
    Content type: Research Published on:

  43. Idiopathic pulmonary fibrosis (IPF) is associated with fatal complications after radiotherapy (RT) for lung cancer patients; however, the role of proton therapy to reduce the incidence of life-threatening comp...

    Authors: Hakyoung Kim, Hongryull Pyo, Jae Myoung Noh, Woojin Lee, Byoungsuk Park, Hye Yun Park and Hongseok Yoo
    Citation: Radiation Oncology 2019 14:19
    Content type: Research Published on:

  44. Preclinical studies suggest enhanced anti-tumor activity with combined radioimmunotherapy. We hypothesized that radiation (RT) + immunotherapy would associate with improved overall survival (OS) compared to im...

    Authors: Corey C. Foster, David J. Sher, Chad G. Rusthoven, Vivek Verma, Michael T. Spiotto, Ralph R. Weichselbaum and Matthew Koshy
    Citation: Radiation Oncology 2019 14:18
    Content type: Research Published on:

  45. Helical irradiation of the total skin (HITS) was modified as simultaneous integrated boost (SIB)-helical arc radiotherapy of total skin (HEARTS) technique and applied to an acute myeloid leukemia (AML) patient...

    Authors: Chen-Hsi Hsieh, Hui-Ju Tien, Yuan-Bin Yu, Yuan-Hung Wu, Pei-Wei Shueng, Yueh-Feng Lu, Shan-Ying Wang and Li-Ying Wang
    Citation: Radiation Oncology 2019 14:17
    Content type: Research Published on:

  46. To evaluate the safety and efficacy of particle therapy (PT) using pencil beam scanning (PBS) technique for early stage non-small cell lung cancer (NSCLC).

    Authors: Jian Chen, Jiade J. Lu, Ningyi Ma, Jingfang Zhao, Chang Chen, Min Fan, Guoliang Jiang and Jingfang Mao
    Citation: Radiation Oncology 2019 14:16
    Content type: Research Published on:

  47. We created a scoring system incorporating dosimetric and clinical factors to assess the risk of severe, acute skin reactions in patients undergoing intensity-modulated radiation therapy (IMRT) to treat head an...

    Authors: Mitsue Kawamura, Michio Yoshimura, Hiromi Asada, Mitsuhiro Nakamura, Yukinori Matsuo and Takashi Mizowaki
    Citation: Radiation Oncology 2019 14:14
    Content type: Research Published on:

  48. The selection of radiation therapy dose fractionation schedules for bone metastases is often based on the estimation of life expectancy. Therefore, accurate prognosis prediction is an important issue. It is re...

    Authors: Hikaru Kubota, Toshinori Soejima, Nor Shazrina Sulaiman, Shuhei Sekii, Yoko Matsumoto, Yosuke Ota, Kayoko Tsujino, Ikuo Fujita, Takuya Fujimoto, Masayuki Morishita, Junichi Ikegaki, Koji Matsumoto and Ryohei Sasaki
    Citation: Radiation Oncology 2019 14:13
    Content type: Research Published on:

  49. The aim of this study is to evaluate the prognostic value of grading MRI–detected skull-base invasion in nasopharyngeal carcinoma (NPC) with skull-base invasion after intensity-modulated radiotherapy (IMRT).

    Authors: Yanru Feng, Caineng Cao, Qiaoying Hu and Xiaozhong Chen
    Citation: Radiation Oncology 2019 14:10
    Content type: Research Published on:

  50. Induction chemotherapy (IC) now is gaining recognition for the treatment of nasopharyngeal carcinoma (NPC). The current study was conducted to examine the association between prognosis and the interval between...

    Authors: Liang Peng, Jin-Qi Liu, Cheng Xu, Xiao-Dan Huang, Ling-Long Tang, Yu-Pei Chen, Ying Sun and Jun Ma
    Citation: Radiation Oncology 2019 14:9
    Content type: Research Published on:
Submit manuscript

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions

Radiation Oncology

ISSN: 1748-717X

Contact us